Abbott Laboratories (VIE:ABT)

Market Cap	201.59B
Revenue (ttm)	36.71B
Net Income (ttm)	11.86B
Shares Out	n/a
EPS (ttm)	6.79
PE Ratio	17.00
Forward PE	24.99
Dividend	2.10 (1.83%)
Ex-Dividend Date	Jul 15, 2025

Volume	n/a
Average Volume	n/a
Open	114.38
Previous Close	112.50
Day's Range	114.16 - 115.12
52-Week Range	100.48 - 134.20
Beta	n/a
RSI	58.63
Earnings Date	Oct 15, 2025

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: ABT

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD